Home

Medicamen Organics Ltd Dividend

Image

Medicamen Organics Ltd

NSE: Medicamen

Dividend Payout (-)

-

Ex-Dividend Date: NA

Key Highlights

  • The Latest Trading Price of Medicamen Organics Ltd is ₹ 59.4 as of 06 Dec 15:30 .

swot
swot

Monitoring Medicamen Organics Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Medicamen Organics Ltd

NSE: Medicamen

Share Price

₹ 59.4

1.15 (1.97%)

stock direction

Last updated on: Dec 06, 2024

Company Fundamentals for Medicamen Organics Ltd

No data available

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis Of Medicamen Organics Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Medicamen Organics Ltd

Historical Market Cap of Medicamen Organics Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Medicamen Organics Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Medicamen Organics Ltd News Hub

Medicamen Organics to discuss results

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 14 November 2024

Read more

09 Nov 2024 14:44

Medicamen Organics to conduct AGM

Medicamen Organics announced that the 29th Annual General Meeting (AGM) of the company will be held

Read more

27 Aug 2024 16:29

NSE SME Medicamen Organics soars on debut

The scrip was listed at Rs 137.85, a premium of 305.44% over the initial public offer (IPO) price. T

Read more

28 Jun 2024 12:45

About Medicamen Organics Ltd

  • Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
  • Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
  • The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions